Levy; Ruth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Levy; Ruth.The latest application filed is for "use of rasagiline for the treatment of restless legs syndrome".

Company Profile

0.25.50

Levy; Ruth - Tel Aviv IL
Levy; Ruth - Collegeville PA
Levy; Ruth - Collegevolle PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20210386690 - Blaugrund; Eran ; et al.	2021-12-16
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20210251921 - Blaugrund; Eran ; et al.	2021-08-19
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20210137852 - Blaugrund; Eran ; et al.	2021-05-13
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20210023026 - Blaugrund; Eran ; et al.	2021-01-28
Rasagiline For The Treatment Of Restless Legs Syndrome App 20200323796 - Blaugrund; Eran ; et al.	2020-10-15
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20200206161 - Blaugrund; Eran ; et al.	2020-07-02
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20200093758 - Blaugrund; Eran ; et al.	2020-03-26
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20190365674 - Blaugrund; Eran ; et al.	2019-12-05
Use of Rasagiline for the Treatment of Restless Legs Syndrome App 20190262284 - Blaugrund; Eran ; et al.	2019-08-29
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20190142766 - Blaugrund; Eran ; et al.	2019-05-16
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20190000780 - Blaugrund; Eran ; et al.	2019-01-03
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20180169038 - Blaugrund; Eran ; et al.	2018-06-21
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20170360723 - Blaugrund; Eran ; et al.	2017-12-21
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20160317471 - Blaugrund; Eran ; et al.	2016-11-03
Use Of Rasagiline For The Treatment Of Restless Legs Syndrome App 20150080441 - Blaugrund; Eran ; et al.	2015-03-19
Use of rasagilline for the treatment of restless legs syndrome Grant 8,946,300 - Blaugrund , et al. February 3, 2	2015-02-03
Combination Therapy With Glatiramer Acetate And Rasagiline For The Treatment Of Multiple Sclerosis App 20140271532 - Kreitman; Rivka ; et al.	2014-09-18
Rasagiline For Parkinson's Disease Modification App 20140243418 - Levy; Ruth ; et al.	2014-08-28
Combination Therapy With Glatiramer Acetate And Rasagiline For The Treatment Of Multiple Sclerosis App 20120027718 - Kreitman; Rivka ; et al.	2012-02-02
Disposable cleaning pad Grant 7,827,650 - Levy , et al. November 9, 2	2010-11-09
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis App 20100167983 - Kreitman; Rivka ; et al.	2010-07-01
Disposable cleaning pad and handle therefor Grant 7,650,664 - Henderson , et al. January 26, 2	2010-01-26
Rasagiline for parkinson's disease modification App 20090312436 - Levy; Ruth ; et al.	2009-12-17
Combination Therapy with Glatiramer Acetate and Rasagiline for the Treatment of Multiple Sclerosis App 20080261894 - Kreitman; Rivka ; et al.	2008-10-23
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis Grant 7,396,860 - Blaugrund , et al. July 8, 2	2008-07-08
Disposable cleaning pad App 20080047087 - Levy; Ruth ; et al.	2008-02-28
Use of rasagilline for the treatment of restless legs syndrome App 20070232700 - Blaugrund; Eran ; et al.	2007-10-04
Disposable cleaning pad and handle therefor App 20070214591 - Henderson; Marianne ; et al.	2007-09-20
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof App 20070100001 - Youdim; Moussa B.H. ; et al.	2007-05-03
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof App 20060094783 - Youdim; Moussa B.H. ; et al.	2006-05-04
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof Grant 6,956,060 - Youdim , et al. October 18, 2	2005-10-18
Immediate release formulation of n-(2-propylpentanoyl)glycinamide App 20040176463 - Licht, Daniella ; et al.	2004-09-09
Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compounds App 20040175423 - Licht, Daniella ; et al.	2004-09-09
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis App 20040127577 - Blaugrund, Eran ; et al.	2004-07-01
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof App 20030212145 - Youdim, Moussa B.H. ; et al.	2003-11-13
Package for carrying plural pantiliners Grant 6,635,039 - Levy October 21, 2	2003-10-21
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof Grant 6,630,514 - Youdim , et al. October 7, 2	2003-10-07
Absorbent article with improved fluid acquisition system and method of making the same Grant 6,566,578 - Glaug , et al. May 20, 2	2003-05-20
Male incontinence absorbent article Grant D473,304 - Harriz , et al. April 15, 2	2003-04-15
Surface pattern for a disposable absorbent article Grant D473,302 - Harriz , et al. April 15, 2	2003-04-15
Male incontinence absorbent article Grant D473,303 - Harriz , et al. April 15, 2	2003-04-15
Use of r-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof App 20030065038 - Youdim, Moussa B.H. ; et al.	2003-04-03
Light , absorbent pad with side leakage barrier system App 20030060792 - Harriz, John ; et al.	2003-03-27
Absorbent article with improved fluid acquisition system Grant 6,509,513 - Glaug , et al. January 21, 2	2003-01-21
Light incontinent product Grant 6,506,961 - Levy January 14, 2	2003-01-14
Absorbent article with improved fluid acquisition system Grant 6,455,753 - Glaug , et al. September 24, 2	2002-09-24
Absorbent article with skin treatment means Grant 6,436,418 - Sheldon , et al. August 20, 2	2002-08-20
Compositions Containing And Methods Of Using 1-aminoindan And Derivatives Thereof And Process For Preparing Optically Active 1-aminoindan Derivatives App 20020068839 - COHEN, SASSON ; et al.	2002-06-06
Absorbent article with improved fluid acquisition system App 20010027302 - Glaug, Frank S. ; et al.	2001-10-04
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,994,408 - Cohen , et al. November 30, 1	1999-11-30
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,914,349 - Cohen , et al. June 22, 1	1999-06-22
R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia Grant 5,891,923 - Youdim , et al. April 6, 1	1999-04-06
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Grant 5,877,221 - Cohen , et al. March 2, 1	1999-03-02
Pharmaceutical composition of L-DOPA ester Grant 5,840,756 - Cohen , et al. November 24, 1	1998-11-24
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof Grant 5,744,500 - Youdim , et al. April 28, 1	1998-04-28
R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof Grant 5,519,061 - Youdim , et al. May 21, 1	1996-05-21
Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase Grant 5,486,541 - Sterling , et al. January 23, 1	1996-01-23
R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them Grant 5,457,133 - Youdim , et al. October 10, 1	1995-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.